Sequencing and analysis of the genome of mycobacterium tuberculosis complex from an isolate or nucleic acid extract: (a) to speciate the organism: (i) at the time of a patient’s initial diagnosis and commencement of initial empiric therapy; or (ii) following recurrence of a patient’s symptoms or a patient’s failure to respond to treatment within the expected timeframe; and (b) for the purpose of: (i) genome‑wide determination of the antimicrobial resistance markers (resistome) of the isolate; and (ii) individualising the patient’s treatment Applicable once at initial diagnosis and once per episode of disease recurrence
Sequencing and analysis of the genome of mycobacterium tuberculosis complex from an isolate or nucleic acid extract: (a) to speciate the organism: (i) at the time of a patient’s initial diagnosis and commencement of initial empiric therapy; or (ii) following recurrence of a patient’s symptoms or a patient’s failure to respond to treatment within the expected timeframe; and (b) for the purpose of: (i) genome‑wide determination of the antimicrobial resistance markers (resistome) of the isolate; and (ii) individualising the patient’s treatment Applicable once at initial diagnosis and once per episode of disease recurrence
No recorded changes yet — history accumulates with each release.
Data sourced from Australian Government publications · Not an official government service